Autor(en) Titel Quelle Links
Rachmilewitz EA, Giardina PJ How I treat thalassemia. [+] Blood 2011, 118: 3479  
Radtke S, Zolk O, Renner B, Paulides M, Zimmermann M, Möricke A, Stanulla M, Schrappe M, Langer T Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity and outcome in childhood acute lymphoblastic leukemia. [+] Blood 2013, Epub ahead of print  
Raimondi SC, Chang MN, Ravindranath Y Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood 1999, 94: 3707  
Rajantie J, Zeller B, Treutiger I, Rosthöj S, NOPHO ITP working group and five national study groups Vaccination associated thrombocytopenic purpura in children. [+] Vaccine 2007, 25: 1838  
Ramakers-van Woerden N, Pieters R, Loonen A, Hubeek I, van Drunen E, Beverloo H, Slater R, Harbott J, Seyfarth J, van Wering E, Hahlen K, Schmiegelow K, Janka-Schaub G, Veerman A TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood 2000, 96: 1094  
Ramakers-van Woerden N, Pieters R, Slater R, Loonen A, Beverloo H, van Drunen E, Heyman M, Moreno T, Rots M, van Wering E, Kamps W, Janka-Schaub G, Veerman A In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia. Br J Haematol 2001, 112: 680  
Ramakers-van Woerden N, Pieters R, Hoelzer D, Slater R, Den Boer M, Loonen A, Harbott J, Janka-Schaub G, Ludwig W, Ossenkoppele G, van Wering E, Veerman A In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age. Med Pediatr Oncol 2002, 38: 379  
Ramakers-van Woerden NL, Beverloo HB, Veerman AJ, Camitta BM, Loonen AH, van Wering ER, Slater RM, Harbott J, den Boer ML, Ludwig WD, Haas OA, Janka-Schaub GE, Pieters R In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. [+] Leukemia 2004, 18: 521  
Raney B, Parham D, Sommelet-Olive D, Stevens M, Treuner J, Carli M Summary of the International Symposium on Childhood Non-Rhabdomyosarcoma Soft-Tissue Sarcomas, Padua, Italy, February 10-12, 1994. Med Pediatr Oncol 1996, 26: 425  
Rasper M, Jabar S, Ranft A, Jürgens H, Amler S, Dirksen U The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma. [+] Pediatric blood & cancer 2014, 61: 1382  
Ratei R, Sperling C, Karawajew L, Schott G, Schrappe M, Harbott J, Riehm H, Ludwig W Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Annals Hematology 1998, 77: 107  
Ratei R, Basso G, Dworzak M, Gaipa G, Veltroni M, Rhein P, Biondi A, Schrappe M, Ludwig WD, Karawajew L, AIEOP-BFM-FCM-MRD-Study Group Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction. [+] Leukemia 2009, 23: 528  
Ratei R, Schabath R, Karawajew L, Zimmermann M, Möricke A, Schrappe M, Ludwig WD Lineage Classification of Childhood Acute Lymphoblastic Leukemia according to the EGIL Recommendations: Results of the ALL-BFM 2000 Trial. [+] Klinische Padiatrie 2013, 225(S 01):S8  
Ravindranath Y, Abella E, Krischer JP, Wiley J, Inoue S, Harris M, Chauvenet A, Alvarado CS, Dubowy R, Ritchey AK et al. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood 1992, 80: 2210  
Redlich A, Boxberger N, Strugala D, Frühwald MC, Leuschner I, Kropf S, Bucsky P, Vorwerk P Systemic Treatment of Adrenocortical Carcinoma in Children: Data from the German GPOH-MET 97 Trial. [+] Klinische Padiatrie 2012, 224: 366  
Redlich A, Boxberger N, Kurt Werner S, Frühwald M, Rohrer T, Vorwerk P Sensitivity of fine-needle biopsy in detecting pediatric differentiated thyroid carcinoma. [+] Pediatric blood & cancer 2012, 59: 233  
Rees DC, Williams TN, Gladwin MT Sickle-cell disease. [+] Lancet 2010, 376: 2018-31.  
Rehan N, Bieling P, Winkler P, Helmke K, Maas R, Baldini N, Heise U, Fuchs N, Winkler K The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy. Klin Pädiatr 1993, 205: 200  
Reiter A, Schrappe M, Ludwig W, Lampert F, Harbott J, Henze G, Niemeyer C, Gadner H, Muller-Weihrich S, Ritter J, Favorable outcome of B-cell acute lymphoblastic leukemia in childhood. Blood 1992, 80: 2471  
Reiter A Therapy of B-cell acute lymphoblastic leukaemia in childhood. Baillieres Clin Haematol 1994, 7: 321  
Reiter A, Schrappe M, Ludwig W, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994, 84: 3122  
Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner H Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood. J Clin Oncol 1994, 12: 899  
Reiter A, Schrappe M, Yakisan E, Sauter S, Ebell W, Zimmermann M, Hartmann W, Kremens B, Kuhn N, Claviez A, Sauerbrey A, Riehm H NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3 Klin Pädiatr 1994, 206: 242  
Reiter A, Schrappe M, Yakisan E, Sauter S, Henzler D, Zimmermann M, Graf N, Fengler R, Kühl J, Fleischhack G, Dörffel W, Kluba U, Riehm H NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 2 Klin Pädiatr 1994, 206: 234  
Reiter A, Tiemann M, Ludwig W, Wacker H, Yakisan E, Schrappe M, Henzler D, Sykora K, Brandt A, Odenwald E, Riehm H, Parwaresch R NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1 Klin Pädiatr 1994, 206: 222  
Reiter A, Zimmermann W, Zimmermann M, Schweinitz D, Riehm H, Mildenberger H The role of initial laparotomy and second-look surgery in the treatment of abdominal B-cell non-Hodgkin's lymphoma of childhood. A report of the BFM Group. Eur J Pediatr Surg 1994, 4: 74  
Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sauter S, Sykora K, Ludwig W, Gadner H, Riehm H Non-Hodgkin's lymphomas of childhood and adolescence. J Clin Oncol 1995, 13: 359  
Zur, Reiter A, Tomeczkowski J, Sykora K A non-radioactive method for detection of monoclonal cell populations in patients with Burkitt's Lymphoma. Molecular Biology of Hematopoiesis 1996, 159  
Reiter A Non-Hodgkin-Lymphome. Diagnostische und therapeutische Standards 1997, 89  
Reiter A, Riehm H Large-cell lymphomas in children. The Non-Hodgkin-Lymphomas 1997, 829  
Reiter A, Seidemann K, Schrappe M Therapie der Non-Hodgkin-Lymphome im Kindesalter. Klin Onkologie 1997, 16  
Zur, Reiter A, Welte K, Sykora K Detection of translocation t(8;14)(q24;132) in pediatric Burkitt's lymphomas using "long distance" polymerase chain reaction. Klin Pädiatr 1997, 209: 165  
Reinhardt D, Pekrun A, Lakomek M, Ritter J, Creutzig U Isolierte Myelosarkome der Haut im Kindesalter. Monatsschrift Kinderheilkunde 1999, 147: 346  
Reinhardt D, Pekrun A, Lakomek M, Ritter J, Creutzig U Primary isolated myeolosarcoma in childhood. Klin Pädiatr 1999, 211: 245  
Reiter A, Schrappe M, Tiemann M, Ludwig W, Yakisan E, Zimmermann M, Mann G, Chott A, Ebell W, Klingebiel T, Graf N, Kremens B, Müller-Weihrich S, Pluss H, Zintl F, Henze G, Riehm H Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy. Blood 1999, 94: 3294  
Reinhardt D, Pekrun A, Lakomek M, Zimmermann M, Ritter J, Creutzig U Primary myelosarcomas are associated with a high rate of relapse. Br J Haematol 2000, 110: 863  
Reiter A, Schrappe M, Ludwig W, Tiemann M, Parwaresch R, Zimmermann M, Schirg E, Henze G, Schellong G, Gadner H, Riehm H Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma. Blood 2000, 95: 416  
Reinhardt D, Lanvers C, Ritter J, and Creutzig U Acute promyelocytic leukemia in children – results of the AML-BFM 93/98 studie. Oncol 2001, 24  
Reinhardt D, Creutzig U Isolated myelosarcoma in children--update and review. Leuk Lymphoma 2002, 43: 565  
Reinhardt D, Hempel G, Fleischhack G, Schulz A, Boos J, Creutzig U Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children. Klin Pädiatr 2002, 214: 188  
Reinhardt D, Hempel G, Fleischhack G, Schulz A, Boos J, Creutzig U Effektive Rezidivtherapie der akuten myeloischen Leukämie im Kindesalter mit liposomalem Daunorubicin und Cytarabin. Klinische Pädiatrie 2002, 214: 188  
Reinhardt D, Langebrake C, Creutzig U, Vormoor J, Brune C, Thorwesten M, Ingiliz P, Hrusak O, Dworzak M, Griesinger F Minimal residual disease in acute myeloid leukemia in children - standardization and evaluation of immunophenotyping in the AML-BFM-98 study. Klinische Pädiatrie 2002, 214: 179  
Reinhardt D, Puhlmann U, Vorwerk H, Creutzig U, Ziemann Ch Impact of Cyclooxygenase-2 Inhibitors on P-Glycoprotein-Mediated Multidrug Resistance in Acute Myeloid Leukemias in Childhood. Blood 2002, 100: 321a-321a  
Reinhardt D, Thiele C, Creutzig U Neuropsychological sequelae in children with AML treated with or without prophylactic CNS-irradiation. Klin Pädiatr 2002, 214: 22  
Reinhardt D, Zimmermann M, Ritter J, Bender-Götze Ch, Creutzig U Comparison of Allogeneic Matched Related Stem Cell Transplantation in 1st CR with Chemotherapy alone in Children with High-Risk AML.  
Reinhardt D, Houliara K, Pekrun A, Lakomek M, Krone B Impact of Conventional Chemotherpy on Levels of Antibodies Against Vaccine-Preventable Diseases in Children Treated for Cancer. Scand J Infect Dis 2003, 35: 851  
Reiter A Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädi-atrische Onkologie und Hämatologie: Non-Hodgkin-Lymphome im Kindesalter. AWMF online 2003  
Reinhard H, Semler O, Burger D, Bode U, Flentje M, Göbel U, Gutjahr P, Leuschner I, Maass E, Niggli F, Scheel-Walter H, Stockle M, Thuroff J, Troger J, Weirich A, von Schweinitz D, Zoubek A, Graf N Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Klin Pädiatr 2004, 216: 132  
Reinhardt D, Diekamp S, Fleischhack G, Corbacioglu S, Jürgens H, Dworzak M, Kaspers G, Creutzig U, Zwaan C Gemtuzumab Ozogamicin (Mylotarg©) in Children with Refractory or Relapsed Acute Myeloid Leukemia. Onkologie 2004, 27: 269  
Reinhardt D, Kurzknabe E, Löffler H, Creutzig U Akute Leukämien im Kindesalter mit besonderer Berücksichtigung der morphologischen Diagnostik. pädiatrische praxis 2004, 64: 395  
Reinhard H, Aliani S, Ruebe C, Stockle M, Leuschner I, Graf N Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study. [+] Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004, 22: 4500  
Reinhardt D, Diekamp S, Langebrake C, Ritter J, Stary J, Dworzak M, Schrauder A, Zimmermann M, Fleischhack G, Ludwig WD, Harbott J, Creutzig U Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment. Leukemia 2005, 19: 1495  
Reinhardt D, Ritter J Klassifikation der Leukämien und malignen Lymphome. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie Berlin, Heidelberg, New York: Springer Verlag, 2006, 647  
Reinhardt D, Ritter J Reaktive Veränderungen des Blutbildes und des Knochenmarks. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie Berlin, Heidelberg, New York: Springer Verlag, 2006, 309  
Reiter A Non-Hodgkin-Lymphome im Kindesalter. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädiatrische Onkologie und Hämatologie 2006  
Reiter A, Mann G, Parwaresch R Non-Hodgkin-Lymphome. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie Berlin, Heidelberg, New York: Springer Verlag, 2006, 733  
Reiche R, Herold R Strukturen in der Pädiatrischen Onkologie und Hämatologie, Ergebnisse der wissenschaftlichen Begleitung der Jahre 2000 - 2006. Js. Karthaus GmbH & Co, Bonn 2007  
Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. [+] Nat Genet 2007, 39: 162  
Reiter A, Klapper W Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. [+] British journal of haematology 2008, 142: 329  
Reinmuth S, Liebeskind AK, Wickmann L, Bockelbrink A, Keil T, Henze G, Borgmann A Having children after surviving cancer in childhood or adolescence - results of a Berlin survey. [+] Klinische Padiatrie 2008, 220: 159  
Reinhard H, Reinert J, Beier R, Furtwängler R, Alkasser M, Rutkowski S, Frühwald M, Koscielniak E, Leuschner I, Kaatsch P, Graf N Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany. [+] Oncology reports 2008, 19: 819  
Reiter A, Wössmann W Non-Hodgkin-Lymphome. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädiatrische Onkologie und Hämatologie 2009  
Reimann, V Stammzellen aus Nabelschnurblut in der Transplantations- und regenerativen Medizin. Dtsch Arztebl 2009, 106: 831  
Reinhardt D, Reinhardt K, Neuhoff C, Sander A, Klusmann JH, Pekrun A, Sauerbrey A, von Stackelberg A, Rössig C, Creutzig U, Kolenova A [GATA1-Mutation Associated Leukemia in Children with Trisomy 21 Mosaic]. [+] Klinische Padiatrie 2012, 224: 153  
Reinhardt D, Von Neuhoff C, Sander A, Creutzig U [Genetic Prognostic Factors in Childhood Acute Myeloid Leukemia.] [+] Klinische Padiatrie 2012, 224: 372  
Reiter A Non-Hodgkin Lymphoma in Children and Adolescents. [+] Klinische Padiatrie 2013, 225(S 01):S87-S93  
Reismüller B, Peters C, Dworzak MN, Pötschger U, Urban C, Meister B, Schmitt K, Dieckmann K, Gadner H, Attarbaschi A, Mann G, on behalf of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group Outcome of Children and Adolescents With a Second or Third Relapse of Acute Lymphoblastic Leukemia (ALL): A Population-based Analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group. [+] Journal of pediatric hematology/oncology 2013, Epub ahead of print  
Reinmuth S, Hohmann C, Rendtorff R, Balcerek M, Holzhausen S, Müller A, Henze G, Keil T, Borgmann-Staudt A Impact of chemotherapy and radiotherapy in childhood on fertility in adulthood: the FeCt-survey of childhood cancer survivors in Germany. [+] Journal of cancer research and clinical oncology 2013, 139: 2071  
Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A, Werft W, Breit S, Liu S, Engel F, Wittmann A, Zimmermann M, Stanulla M, Schrappe M, Ludwig WD, Bartram CR, Radlwimmer B, Muckenthaler MU, Lichter P, Kulozik AE High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16. 1 as a genomic marker for unfavorable early treatment response. [+] Blood 2009, 114: 1053  
Remke M, Hering E, Gerber NU, Kool M, Sturm D, Rickert CH, Gerß J, Schulz S, Hielscher T, Hasselblatt M, Jeibmann A, Hans V, Ramaswamy V, Taylor MD, Pietsch T, Rutkowski S, Korshunov A, Monoranu CM, Frühwald MC Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma. [+] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2013, 29: 1253  
Renbarger JL, McCammack KC, Rouse CE, Hall SD Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. [+] Pediatric blood & cancer 2008, 50: 769  
Renella R, Wood WG The congenital dyserythropoietic anemias. [+] Hematology/oncology clinics of North America 2009, 23: 283  
Rendtorff R, Hohmann C, Reinmuth S, Müller A, Dittrich R, Beyer M, Wickmann L, Keil T, Henze G, Borgmann-Staudt A Hormone and Sperm Analyses after Chemo- and Radiotherapy in Childhood and Adolescence. [+] Klinische Padiatrie 2010, 222: 145  
Rendtorff R, Beyer M, Müller A, Dittrich R, Hohmann C, Keil T, Henze G, Borgmann A Low inhibin B levels alone are not a reliable marker of dysfunctional spermatogenesis in childhood cancer survivors. [+] Andrologia 2011, [Epub ahead of print]  
Reulen RC, Zeegers MP, Wallace WH, Frobisher C, Taylor AJ, Lancashire ER, Winter DL, Hawkins MM, British Childhood Cancer Survivor Study Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study. [+] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009, 18: 2239  
Rhodes MM, Bates DG, Andrews T, Adkins L, Thornton J, Denham JM Abdominal pain in children with sickle cell disease. [+] Journal of clinical gastroenterology 2014, 48: 99  
Rickert CH, Strater R, Kaatsch P, Wassmann H, Jürgens H, Dockhorn-Dworniczak B, Paulus W Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 2001, 158: 1525  
Richter-Unruh A Pubertas präcox - Pubertas tarda bei Mädchen. ÄP Gynäkologie 4_2012  
Riehm H, Gadner H, Welte K Die West-Berliner Studie zur Behandlung der akuten lymphoblastischen Leukämie des Kindes -Erfahrungsbericht nach 6 Jahren. Klin. Pädiat.1977 189; 89  
Riehm H, Gadner H, Langermann HJ, Odenwald E, Henze G The Berlin Childhood Acute lymphoblastic Leukemia Therapy Study, 1970-1976. Am J Pediatr Hematol Oncol 1980, 2: 299  
Riehm H, Gadner H, Henze G, Kornhuber B, Lampert F, Niethammer D, Reiter A, Schellong G Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematology and blood transfusion 1990, 33: 439  
Rieden K, Weirich A, Tröger J, Ludwig R Tumor response to pre-operative chemotherapy in nephroblastoma. Advanced radiation therapy, tumor response monitoring and treatment planning 1992, 249  
Rieden K, Weirich A, Tröger J, Gamroth H, Raschke K, Ludwig R Accuracy of diagnostic imaging in nephroblastoma before preoperative chemotherapy. Eur Radiol 1993, 3: 115  
Riede UN (Hrsg) Allgemeine und spezielle Pathologie. Georg-Thieme-Verlag 5. komplett überarb. Aufl., 2004  
Ritter J, Creutzig U, Riehm H, Schellong G Acute myelogenous leukemia. Recent Results Cancer Res 1984, 93: 204  
Ritter J, Creutzig U, Riehm H, Brandeis W, Gerein V, Prindull G, Rister M, Schellong G Improved treatment results in childhood acute myelogenous leukemia. Haematology and Blood Transfusion 1985, 29: 82  
Ritter J, Creutzig U, Schellong G Risikogruppen bei der akuten, nicht-lymphatischen Leukämie im Kindesalter. Analyse der Ergebnisse der kooperativen Therapiestudien AML-BFM-78 and 83. Onkologie 1986, 9: 78  
Ritter J, Creutzig U, Henze G, Jürgens H, Bode U, Prindull G, Schellong G High dosage ARA-C in combination with mitoxantrone in therapy of acute myeloid leukemia in childhood. Initial results of the AML BFM-85 recurrence study. Onkologie 1987, 10: 24  
Ritter J, Creutzig U, Hiddemann W, Schellong G Mitoxantron in Kombination mit hochdosiertem ARA-C als Therapiemöglichkeit bei der AML im Kindesalter. Fortschr antimikr antineoplast Chemother 6-9 1987, 1517-1521, 1987  
Ritter J, Voigt D, Hoese G, Schellong G Special aspects of supportive therapy in childhood acute leukemias. Haematol Bluttransfus 1987, 30: 182  
Ritter J Diagnostik und Therapie der akuten Leukämien. Onkol Forum Chemotherapie 1988, 2: 1  
Ritter J, Vormoor J, Creutzig U, Schellong G Prognostic significance of Auer rods in childhood acute myelogenous leukemia. Med Pediatr Oncol 1989, 17: 202  
Ritter J, Creutzig U, Jobke A, Lampert F, Reiter A, Schellong G Acute myelogenous leukemia in the first year of life. Contrib Oncol 1990, 41: 30  
Ritter J, Creutzig U, Reiter A, Riehm H, Schellong G Childhood leukemia. J Cancer Res Clin Oncol 1990, 116: 100  
Ritter J, Creutzig U, Schellong G Improved treatment results in the myelocytic subtypes FAB M1- M4 but not in FAB M5 after intensification of induction therapy. Haematology and Blood Transfusion 1990, 33: 185  
Ritterbach J, Harbott J, Ritter J, Lampert F Chromosomal aberrations in childhood acute nonlymphoblastic leukemia. Hamatol Bluttransfus 1990, 33: 153  
Ritter J, Creutzig U, Schellong G Treatment results of three consecutive German childhood AML trials. Leukemia 1992, 6: 59  
Ritter J, Creutzig U, Schellong G, Group for Treatment of refractory and relapsed childhood acute myelogenous leukemia with high dose cytosine arabinoside and mitoxantrone (HAM). Haematology and Blood Transfusion 1992, 34: 418  
Ritter J Diagnostic and therapy of systemic fungal infections in children with hematological malignancies. Res Clin Oncol 1994, 120  
Ritter J, Roos N Special aspects related to invasive fungal infections in children with cancer. Bailliere's Clin Inf Dis 1995, 2: 179  
Ritter J, Creutzig U, Zimmermann M The specific role of Idarubicin during Induction therapy of childhood AML. Haematology and Blood Transfusion 1996, 38: 396  
Ritter J Acute myeloid leukaemias. Eur J Cancer 1998, 34: 862  
Ritterbach J, Hiddemann W, Beck J, Schrappe M, Janka-Schaub G, Ludwig W, Harbott J, Lampert F Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH). Leukemia 1998, 12: 427  
Ritter J, Schrappe M Theray of lymphoblastic leukemia. Paediatric Haematology 1999  
Rizzari C, Conter V, Starý J, Colombini A, Moericke A, Schrappe M Optimizing asparaginase therapy for acute lymphoblastic leukemia. [+] Current opinion in oncology 2013, 25 Suppl 1:S1  
Roach ES, Gomez MR, Northrup H Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998, 83: 624-8.  
Robison LL, Buckley JD, Daigle AE, Wells R, Benjamin D, Arthur DC, Hammond GD Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer 1989, 63: 1904  
Robertson PL, Muraszko KM, Holmes EJ, Sposto R, Packer RJ, Gajjar A, Dias MS, Allen JC, Children's Oncology Group Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. [+] Journal of neurosurgery 2006, 105(6 Suppl): 444  
Robinson TM, Fuchs EJ Allogeneic stem cell transplantation for sickle cell disease. Current opinion in hematology 2016, 23: 524  
Rodriguez T, Baumgarten E, Fengler R, Soumpasis D, Henze G Long-term infusion of L-asparaginase--an alternative to intramuscular injection? Klin Pädiatr 1995, 207: 207  
Rodl R, Hoffmann C, Gosheger G, Leidinger B, Jürgens H, Winkelmann W Ewing's sarcoma of the pelvis. J Surg Oncol 2003, 83: 154  
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. [+] Blood 2009, 113: 2386  
Rodeghiero F, Ruggeri M Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? [+] British journal of haematology 2012l; 158: 16  
Roessner A, Jürgens H Round cell tumours of bone. Pathol Res Pract 1993, 189: 111  
Rösler P, Christiansen H, Kortmann RD, Martini C, Matuschek C, Meyer F, Rübe C, Langer T, Koch R, Eich HT, Willich N, Steinmann D Hepatotoxicity after liver irradiation in children and adolescents : Results from the RiSK. [+] Strahlentherapie und Onkologie 2015, 191: 413  
Rogge T, Niemeyer C Myelodysplastic syndromes in childhood. Onkologie 2000, 23: 18  
Rohrschneider W, Weirich A, Rieden K, Darge K, Troger J, Graf N US, CT and MR imaging characteristics of nephroblastomatosis. Pediatr Radiol 1998, 28: 435  
Rohmer B, Valla FV, Baleydier F, Launay V, Dommange-Romero F, Pondarré C Newly Diagnosed Immune Thrombocytopenic Purpura in Childhood: Successful Implementation of a Limited Intervention Strategy in the Setting of Pediatric Emergency Care. [+] The Journal of pediatrics 2014, Epub ahead of print  
Rokes CA, Remke M, Guha-Thakurta N, Witt O, Korshunov A, Pfister S, Wolff JE Sorafenib plus valproic acid for infant spinal glioblastoma. [+] J Pediatr Hematol Oncol 2010, 32: 511  
Rolf N, Bugert P, Gehrisch S, Siegert G, Suttorp M, Knöfler R [Clinical and laboratory aspects of the Aspirin-like defect as hereditary thrombocytopathy]. [+] Hamostaseologie 2009, 29: 177  
Romanowski R, Schott C, Issels R, Klingebiel T, Treuner J, Jürgens H, Göbel U, Goldschmitt-Wuttge B, Feldmann H, Haas R Regional hyperthermia with systemic chemotherapy in children and adolescents. Klinische Pädiatrie 1993, 205: 249  
Rossi R, Helmchen U, Schellong G Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases. Eur J Pediatr 1992, 151: 384  
Rossi R, Ehrich J Partial and complete de Toni-Debre-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy. Eur J Clin Pharmacol 1993, 44 Suppl 1:S43-5:S43-S45  
Rossi R, Kleinebrand A, Godde A, Rath B, Jürgens H Increased risk of ifosfamide-induced renal Fanconi's syndrome after unilateral nephrectomy [letter]. Lancet 1993, 341  
Rossi R, Rath B, Ullrich K, Ehrich J Ifosfamide-induced nephrotoxicity. Monatsschr Kinderheilkd 1993, 141: 594  
Rossi R, Danzebrink S, Hillebrand D, Linnenburger K, Ullrich K, Jürgens H Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum. Med Pediatr Oncol 1994, 22: 27  
Rossi R, Danzebrink S, Linnenburger K, Hillebrand D, Gruneberg M, Sablitzky V, Deufel T, Ullrich K, Harms E Assessment of tubular reabsorption of sodium, glucose, phosphate and amino acids based on spot urine samples. Acta Paediatr 1994, 83: 1282  
Rossi R, Godde A, Kleinebrand A, Riepenhausen M, Boos J, Ritter J, Jürgens H Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity. J Clin Oncol 1994, 12: 159  
Rossi R, Kist C, Wurster U, Kulpmann W, Ehrich J Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis. Pediatr Nephrol 1994, 8: 151  
Rossi R, Godde A, Kleinebrand A, Rath B, Jürgens H Concentrating capacity in ifosfamide-induced severe renal dysfunction. Ren Fail 1995, 17: 551  
Rossi R Nephrotoxicity of ifosfamide--moving towards understanding the molecular mechanisms [editorial]. Nephrol Dial Transplant 1997, 12: 1091  
Rossi R, Schäfers P, Pleyer J, Postler Ch, Boos J, Jürgens H The influence of short versus continious ifosfamide infusion on the development of renal tubular impairment. J Ped Hematol/Oncol 1997, 4: 393  
Rossi R, Kleta R, Ehrich J Renal involvement in children with malignancies. Pediatr Nephrol 1999, 13: 153  
Rossi R, Pleyer J, Schäfers P, Kuhn N, Kleta R, Deufel T, Jürgens H Development of ifosfamide-induced nephrotoxicity. Med Pediatr Oncol 1999, 32: 177  
Rosenthal H, Kolb R, Gratz K, Reiter A, Galanski M Bone manifestations in non-Hodgkin's lymphoma in childhood and adolescence. Radiologe 2000, 40: 737  
Rosthøj S, Hedlund-Treutiger I, Rajantie J, Zeller B, Jonsson OG, Elinder G, Wesenberg F, Henter JI, NOPHO ITP Working Group Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort. [+] The Journal of pediatrics 2003, 143: 302  
Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC, Severe Chronic Neutropenia International Registry The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. [+] Blood 2006, 107: 4628  
Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link DC, Newburger PE, Shimamura A, Welte K, Dale DC Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. [+] British journal of haematology 2010, 150: 196  
Rossig C, Jürgens H, Schrappe M, Moericke A, Henze G, von Stackelberg A, Reinhardt D, Burkhardt B, Woessmann W, Zimmermann M, Gadner H, Mann G, Schellong G, Mauz-Koerholz C, Dirksen U, Bielack S, Berthold F, Graf N, Rutkowski S, Calaminus G, Kaatsch P, Creutzig U Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria. [+] Pediatric blood & cancer 2013, 60: 1574  
Rosolen A, Perkins SL, Pinkerton CR, Guillerman RP, Sandlund JT, Patte C, Reiter A, Cairo MS Revised International Pediatric Non-Hodgkin Lymphoma Staging System. [+] Journal of clinical oncology 2015, 33: 2112  
Roth H, Weirich A, Ludwig R, Daum R, Zimmermann H Resection of nephroblastoma. Langenbecks Arch Chir Suppl Kongressbd 1996, 113: 1078  
Rots M, Pieters R, Peters G, Noordhuis P, van Zantwijk C, Kaspers G, Hählen K, Creutzig U, Veerman A, Jansen G Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolates. Blood 1999, 54: 3121  
Rots M, Pieters R, Peters G, Noordhuis P, van Zantwijk C, Kaspers G, Hählen K, Creutzig U, Veerman A, Jansen G Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accummulation and polyglutamylation in childhood leukemia. Blood 1999, 93: 1677  
Rots M, Pieters R, Peters G, Noordhuis P, van Zantwijk C, Henze G, Janka-Schaub G, Veerman A, Jansen G Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 2000, 109: 629  
Rots M, Pieters R, Peters G, Noordhuis P, van Zantwijk C, Henze G, Janka-Schaub G, Veerman A, Jansen G Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 2000, 109: 629  
Rots M, Pieters R, Jansen G, Kaspers G, van Zantwijk C, Noordhuis P, Voorn D, van Wering E, Creutzig U, Veerman A, Peters G A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia. Eur J Cancer 2001, 37: 492  
Roth CL, Hunneman DH, Gebhardt U, Stoffel-Wagner B, Reinehr T, Müller HL Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. [+] Pediatr Res 2007, 61: 496  
Roth CL, Gebhardt U, Müller HL Appetite-regulating hormone changes in patients with craniopharyngioma. [+] Obesity 2011, 19: 36  
Royer-Pokora B, Graf N Wilms tumors arising at young age: a genetic basis to distinguish subgroups for individualized therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jun 1; 29:e485-6; author reply e487  
Rozen WM, Joseph S, Lo PA Spontaneous regression of low-grade gliomas in pediatric patients without neurofibromatosis. [+] Pediatric neurosurgery 2008, 44: 324  
Rube C, van Valen F, Wilfert F, Palm J, Schuck A, Willich N, Winkelmann W, Jürgens H, Rube C Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (tnf-alpha) after radiation exposure. Int J Radiat Oncol Biol Phys 2003, 56: 1414  
Rudolph P, Lappe T, Hero B, Berthold F, Parwaresch R, Harms D, Schmidt D Prognostic significance of the proliferative activity in neuroblastoma. Am J Pathol 1997, 150: 133  
Rudnik-Schoneborn S, Anhuf D, Koscielniak E, Zerres K Alveolar rhabdomyosarcoma in infantile spinal muscular atrophy: coincidence or predisposition? [+] Neuromuscular disorders 2005, 15: 45  
Rühl U, Albrecht M, Dieckmann K, Lüders H, Marciniak H, Schellenberg D, Wickmann L, Dörffel W Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease. Int J Radiation Oncology Biol Phys 2001, 51: 1209  
Ruge MI, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F, Maarouf M, Treuer H, Berthold F, Sturm V, Voges J Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome. [+] Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Nov 1; 29: 4151  
Ruggeri A, Michel G, Dalle JH, Caniglia M, Locatelli F, Campos A, Diaz de Heredia C, Mohty M, Perez Hurtado JM, Bierings M, Bittencourt H, Mauad M, Purtill D, Cunha R, Kabbara N, Gluckman E, Labopin M, Peters C, Rocha V Impact of pre-transplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission. An Eurocord, PDWP-EBMT analysis. [+] Leukemia 2012, [Epub ahead of print]  
Ruhnke M, Rickerts V, Cornely OA, Buchheidt D, Glöckner A, Heinz W, Höhl R, Horré R, Karthaus M, Kujath P, Willinger B, Presterl E, Rath P, Ritter J, Glasmacher A, Lass-Flörl C, Groll AH Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. [+] Mycoses 2011 54: 279  
Ruland V, Hartung S, Kordes U, Wolff JE, Paulus W, Hasselblatt M Choroid plexus carcinomas are characterized by complex chromosomal alterations related to patient age and prognosis. [+] Genes, chromosomes & cancer 2014, 53: 373  
Rund D, Rachmilewitz E Beta-thalassemia. The New England journal of medicine 2005, 353: 1135  
Rutkowski S, De Vleeschouwer S, Kaempgen E, Wolff JE, Kühl J, Demaerel P, Warmuth-Metz M, Flamen P, Van Calenbergh F, Plets C, Sörensen N, Opitz A, Van Gool SW Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study. Br J Cancer 2004, 91: 1656  
Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. [+] The New England journal of medicine 2005, 352: 978  
Rutkowski S, Warmuth-Metz M, Sörensen N, Faldum A, Pietsch T, Müller H, Gnekow A, Göbel U, Wolff J, Fleischhack G, Kortmann R Hirntumoren im Kindesalter. Diagnostik und interdisziplinäre Therapiekonzepte. Der Onkologe Band 2005, Heft 10,  
Rutkowski S Current treatment approaches to early childhood medulloblastoma. [+] Expert Rev Neurother 2006, 6: 1211  
Rutkowski S Timely identification of suspected paediatric CNS tumours. The lancet oncology 2007, 8: 664  
Rutkowski S, von Bueren A, von Hoff K, Hartmann W, Shalaby T, Deinlein F, Warmuth-Metz M, Soerensen N, Emser A, Bode U, Mittler U, Urban C, Benesch M, Kortmann RD, Schlegel PG, Kuehl J, Pietsch T, Grotzer M Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91. [+] Clinical cancer research 2007, 13: 2651  
Rutkowski S, Riehle E Access to employment and economic independence in cerebral palsy. [+] Physical medicine and rehabilitation clinics of North America 2009, 20: 535  
Rutkowski S, Gerber NU, von Hoff K, Gnekow A, Bode U, Graf N, Berthold F, Henze G, Wolff JE, Warmuth-Metz M, Soerensen N, Emser A, Ottensmeier H, Deinlein F, Schlegel PG, Kortmann RD, Pietsch T, Kuehl J, German Pediatric Brain Tumor Study Group Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. [+] Neuro-oncology 2009, 11: 201  
Rutkowski S, von Hoff K, Emser A, Zwiener I, Pietsch T, Figarella-Branger D, Giangaspero F, Ellison DW, Garre ML, Biassoni V, Grundy RG, Finlay JL, Dhall G, Raquin MA, Grill J Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. [+] J Clin Oncol 2010, 28: 4961  
Rutkowski S, Cohen B, Finlay J, Luksch R, Ridola V, Valteau-Couanet D, Hara J, Garre ML, Grill J Medulloblastoma in young children. [+] Pediatr Blood Cancer 2010, 54: 635  
Rutkowski S Medulloblastom im Kindes- und Jugendalter. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie. AWMF online 2012  
Rutkowski S, Trollmann R, Korinthenberg R, Warmuth-Metz M, Weckesser M, Krauss J, Pietsch T Leitsymptome und Diagnostik der ZNS-Tumoren im Kindes- und Jugendalter. Gemeinsame Leitlinie der Gesellschaft für Neuropädiatrie und der Gesellschaft für Pädiatrische Onkologie und Hämatologie 2016  
Ruutu T, de Wreede LC, van Biezen A, Brand R, Mohty M, Dreger P, Duarte R, Peters C, Garderet L, Schönland S, Gratwohl A, Niederwieser D, de Witte T, Kröger N Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. [+] Bone Marrow Transplant 2015, 50: 1542  
172 items found

Die Literatur-Datenbank ist alphabetisch nach dem Namen des Erstautors sortiert - bitte anklicken. Sie umfasst alle Angaben, die im Laufe der letzten Jahre von den Studienzentralen ausgewählt wurden oder die in diesem Informationsangebot referenziert werden, zum Beispiel in den Patienteninformationstexten.